Clinical Trial: Efficacy and Safety of HRS9531 in Participants With Type 2 Diabetes Treated With Basal Insulin

U.S., July 12 -- ClinicalTrials.gov registry received information related to the study (NCT07060456) titled 'Efficacy and Safety of HRS9531 in Participants With Type 2 Diabetes Treated With Basal Insulin' on June 22.

Brief Summary: The study is being conducted to evaluate the efficacy and safety of HRS9531 compared with placebo in participants with type 2 diabetes mellitus not adequately controlled with basal insulin, with or without metformin and/or sodium-glucose cotransporter-2 (SGLT2) inhibitor. The study may include up to 23 visits.

Study Start Date: July, 2025

Study Type: INTERVENTIONAL

Condition: Type 2 Diabetes

Intervention: DRUG: HRS953

HRS953-low dose

DRUG: HRS953

HRS953-high dose

DRUG: Placebo

Placebo

Recruitment Sta...